Dr Martha Gulati (Head of Cardiology, University of Arizona College of Medicine, Phoenix, AZ, USA) discusses the subject of women and cardiovascular disease, the difference between sex and gender and how both sex and gender can affect diagnosis and treatment of cardiovascular disease.
Filmed at ESC 2018, Munich.
View more content here.
Speaker Disclosure: Dr Martha Gulati has nothing to disclose in relation to this video interview.
1. How has our understanding of the role of gender in cardiovascular disease changed over the last few decades?
2. What differences are there between men and women in terms of risk factors for cardiovascular disease? (0:08)
3. Are there any gender differences in treatment responses and outcomes? (3:22)
4. Please describe any ongoing projects and programs there are to better understand and treat cardiovascular disease in women? (0:08)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via open-access content in multimedia formats.
Share this Video
Related Videos In Cardiovascular Disease
William Schulyer-Jones, ACC 2021 – Findings from the ADAPTIVE study
We were delighted to speak with Dr William Schulyer-Jones (Associate Professor of Medicine, Duke University School of Medicine, Durham, NC, USA) about the findings of the ADAPTABLE STUDY, a large randomized study assessing the benefits and long-term effectiveness of aspirin dosage (81 mg vs. 325mg) for patients with cardiovascular disease. Abstract title: Aspirin Dosing: A […]
Gustavo Samaja, ESC 2020 – Myocardial Infarction with no Obstructive Coronary Arteries
We spoke to Dr Gustavo Samaja (Policlinico Bancario, Buenos Aires, Argentina) about myocardial infarction with no obstructive coronary arteries (MINOCA), and especially its prevalence and importance during the COVID-19 pandemic. Questions Could you give us a brief overview of myocardial infarction with no obstructive coronary arteries (MINOCA)? (0:33) How prevalent is MINOCA and what […]
David Playford, ESC 2020 – Diastolic Function and Mortality Part 1
We spoke to Professor David Playford (University of Notre Dame, Perth, Australia) regarding diastolic function and dysfunction, the National Echo Database Australia (NEDA), and then focused on his recent study on diastolic function and mortality. Questions What are the prognostic implications of diastolic dysfunction? (0:07) How do you classify patients by diastolic function? (1:18) […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!